Lateral Flow Assays Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson, and Company
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F.Hoffmann-La Roche AG
- QIAGEN N.V.
- Siemens Healthineers AG
- Thermo Fisher Scientific, Inc.
- Merck kGaA
- PerkinElmer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of lateral flow assays is assessed at USD 10.3 billion.
The global lateral flow assays market size surpassed USD 9.76 billion in 2025 and is projected to witness a CAGR of around 6.2%, crossing USD 17.81 billion revenue by 2035.
Asia Pacific lateral flow assays market will secure around 34% share by 2035, driven by high burden of infectious diseases requiring rapid diagnosis.
Key players in the market include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kGaA, PerkinElmer Inc.
